Viroforge Technologies develops miniaturized lab-on-a-chip diagnostics for infectious diseases, bringing complex, quantitative testing to the point of care. Its VPLEX™ platform uses sealed, single-use cassettes and a fingerstick blood sample to deliver multiplexed results and analysis in about 20 minutes, without conventional laboratory infrastructure. The Frederick, Maryland company applies the platform to needs ranging from COVID-19 immune-response assessment to antibiotic stewardship and emerging-disease surveillance.